- Zoster (Shingles)
- Vaccine Recommendations
Will administering zoster vaccine reduce the risk of postherpetic neuralgia (PHN) if a vaccinated person develops shingles?
Yes. In clinical trials among immunocompetent adults age 50 years or older, Shingrix reduced the risk of PHN by 91%. One study among hematopoietic cell transplant recipients reported that vaccination reduced the risk of PHN by 89%.
Last reviewed:
March 9, 2022